BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 24461102)

  • 1. [Hereditary pigmentary disorders: light from the East].
    Dereure O
    Ann Dermatol Venereol; 2014 Jan; 141(1):77-8. PubMed ID: 24461102
    [No Abstract]   [Full Text] [Related]  

  • 2. Functional implications of novel ADAM10 mutations in reticulate acropigmentation of Kitamura.
    Ralser DJ; Lestringant GG; Du-Thanh A; Kokordelis P; Fischer J; Basmanav FBÜ; Wolf S; Thiele H; Altmüller J; Nürnberg P; Oji V; Fritz G; Frank J; Betz RC
    Br J Dermatol; 2017 Dec; 177(6):e340-e343. PubMed ID: 29192958
    [No Abstract]   [Full Text] [Related]  

  • 3. Genome-wide linkage and exome sequencing analyses identify an initiation codon mutation of KRT5 in a unique Chinese family with generalized Dowling-Degos disease.
    Li M; Wang J; Zhang J; Ni C; Li X; Liang J; Cheng R; Li Z; Yao Z
    Br J Dermatol; 2016 Mar; 174(3):663-6. PubMed ID: 26440693
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyschromatosis symmetrica hereditaria and reticulate acropigmentation of Kitamura: An update.
    Kono M; Akiyama M
    J Dermatol Sci; 2019 Feb; 93(2):75-81. PubMed ID: 30692041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
    Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
    Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulate acropigmentation of Kitamura with a novel ADAM10 mutation: A case report.
    Tsutsumi M; Kono M; Akiyama M; Katoh N; Nakai N
    J Dermatol; 2016 Aug; 43(8):963-5. PubMed ID: 26892935
    [No Abstract]   [Full Text] [Related]  

  • 7. Reticulate acropigmentation of Kitamura with a novel mutation in ADAM10.
    Pan Y; Zhong W; Wang H; Yang Y; Lin Z
    Clin Exp Dermatol; 2019 Aug; 44(6):700-703. PubMed ID: 30488468
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mutations in presenilin in Dowling-Degos disease: Association with follicular occlusion disorder and the notch-signalling pathway].
    Dereure O
    Ann Dermatol Venereol; 2017 Dec; 144(12):825-826. PubMed ID: 29100615
    [No Abstract]   [Full Text] [Related]  

  • 9. Vulvar Dyschromia in a Child: A Quiz.
    de Lorenzi C; Kaya G; Quenan S; Calza AM
    Acta Derm Venereol; 2019 Jun; 99(7):711-712. PubMed ID: 30938832
    [No Abstract]   [Full Text] [Related]  

  • 10. Comorbidities or different entities? Phenotype variability associated with PSENEN mutations.
    Li W; Xu H; He Y; Lin L; Li C
    Br J Dermatol; 2019 Jan; 180(1):221-222. PubMed ID: 30144026
    [No Abstract]   [Full Text] [Related]  

  • 11. Dowling-Degos disease with mutation in the exon 1 of the keratin 5 gene.
    Yu W; Gan L; Wu J; Sun J; Jiang Y
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e14-e15. PubMed ID: 28646612
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutations in γ-secretase subunit-encoding PSENEN underlie Dowling-Degos disease associated with acne inversa.
    Ralser DJ; Basmanav FB; Tafazzoli A; Wititsuwannakul J; Delker S; Danda S; Thiele H; Wolf S; Busch M; Pulimood SA; Altmüller J; Nürnberg P; Lacombe D; Hillen U; Wenzel J; Frank J; Odermatt B; Betz RC
    J Clin Invest; 2017 Apr; 127(4):1485-1490. PubMed ID: 28287404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Of hair and genes: The continuing story of Dowling-Degos disease].
    Dereure O
    Ann Dermatol Venereol; 2015 Jan; 142(1):74-5. PubMed ID: 25530071
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenicity of POFUT1 mutations in two Chinese families with Dowling-Degos disease.
    Li CR; Brooks YS; Jia WX; Wang DG; Xiao XM; Li Q; Li M; Mao QX; Wang B
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e79-e81. PubMed ID: 26486618
    [No Abstract]   [Full Text] [Related]  

  • 15. Updated review of genetic reticulate pigmentary disorders.
    Zhang J; Li M; Yao Z
    Br J Dermatol; 2017 Oct; 177(4):945-959. PubMed ID: 28407215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dowling-Degos disease: a review.
    Stephan C; Kurban M; Abbas O
    Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura.
    Buket Basmanav F; Fritz G; Lestringant GG; Pachat D; Hoffjan S; Fischer J; Wehner M; Wolf S; Thiele H; Altmüller J; Pulimood SA; Rütten A; Kruse R; Hanneken S; Frank J; Danda S; Bygum A; Betz RC
    J Invest Dermatol; 2015 Feb; 135(2):615-618. PubMed ID: 25229252
    [No Abstract]   [Full Text] [Related]  

  • 18. A new nonsense mutation in the POGLUT1 gene in two sisters with Dowling-Degos disease.
    Duchatelet S; Clerc H; Machet L; Gaboriaud P; Miskinyte S; Kervarrec T; Hovnanian A
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e440-e442. PubMed ID: 29569780
    [No Abstract]   [Full Text] [Related]  

  • 19. Atypical presentation of Dowling-Degos disease with novel and recurrent mutations in POFUT1.
    Zhong W; Liu J; Wang H; Dou X; Yu B; Lin Z; Yang Y
    Clin Exp Dermatol; 2018 Dec; 43(8):937-939. PubMed ID: 29797344
    [No Abstract]   [Full Text] [Related]  

  • 20. Vesicular variant of Dowling-Degos disease.
    Linke M; Orouji A; Géraud C
    Br J Dermatol; 2018 Sep; 179(3):795-796. PubMed ID: 29931677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.